News

Systemic Biologics Might Revolutionize the Treatment of Atopic Dermatitis

Author and Disclosure Information

 

EXPERT ANALYSIS FROM THE CARIBBEAN DERMATOLOGY SYMPOSIUM

References

Customer service is another focus at the university. If patients or parents feel better about their visits – not just with the doctor, but from their appointment phone calls right through to their checkouts – they are more likely to stick with treatments.

Dr. Ellis leads a service excellence program to train physicians, nurses, and ancillary staff to ensure that visits go well and patient needs are met. It’s “similar to what you might find in a fancy hotel chain,” and has proven itself with high patient satisfaction scores, he said.

A thorough history is part of good customer service. One thing to pay attention to is calcium channel blocker and thiazide use in older patients.

Both can cause chronic eczematous eruptions that look like atopic dermatitis, and elderly people might have been on the drugs for so long that the relationship with skin problems is easy to miss.

“If you haven’t contemplated particularly calcium channel blockers as a potential cause, you might not give patients a chance to go off them for a while to see if it helps,” he said.

Global Academy and this news organization are owned by the same parent company.

Dr. Ellis is a consultant for Celgene, Ferndale, Otsuka, and Johnson & Johnson.

Pages

Recommended Reading

Indoor Tanning Rates Down for High School Students in 2013
Clinician Reviews
Excessive Sun Damage and a “Fungal Infection”?
Clinician Reviews
Open Wide: New Insights Into Burning Mouth Syndrome
Clinician Reviews
Annual Costs of Psoriasis Top $112 Billion
Clinician Reviews
Skin Markers of Nutritional Deficiency Are Not Uncommon
Clinician Reviews
Efinaconazole Topical Solution Effective Against Early Onychomycosis
Clinician Reviews
Tiny Lesion Turns Troublesome After Trauma
Clinician Reviews
Psoriasis Treatment Recommendations Address Four Clinical Scenarios
Clinician Reviews
Adults With Eczema Face Increased Risk of Fracture and Bone or Joint Injuries
Clinician Reviews
Secukinumab Earns FDA Approval for Plaque Psoriasis
Clinician Reviews